French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for $9.5 billion, sending shares of the ...

P&G saw three new federal suits that center on allegedly deceptive environmental claims on its Charmin and Puffs paper ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies insisted the sensitive genetic data provided to 23andMe by 15 million ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

President Trump signs an executive order to reduce prescription drug costs in the U.S. Discover the changes and potential impacts.

A week after one New Haven-based biotechnology company announced a mass layoff, another has announced plans to cut 40% of its workforce. RallyBio, based at 234 Church St., in New Haven ...

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release.

The company said in a release last month about a human clinical trial that it is “a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

Belfast-founded biotech company Amply Discovery has raised $1.75 million (about £1.3 million) in seed funding to develop innovative medicines using its proprietary AI-driven drug discovery platform.

The recently announced expansion will add to the roughly 400 jobs already promised in central Ohio by the biotech company and bring its total local investment to $1.4 billion. The expansion is on ...